Reasons to Retain ABT Stock in Your Portfolio Now

Abbott Laboratories’ (ABT) growth in the third quarter of 2024 can be attributed to strong sales recovery within the Nutrition business, driven by the robust sales performance of Ensure, the company’s market-leading complete and balanced nutrition brand. The company is driving solid growth in emerging markets within the EPD business. However, the runoff of COVID testing revenues and currency fluctuations may restrict Abbott’s growth potential.In the past year, this Zacks Rank #3 (Hold) company’s shares have ...